Abstract
Hepatitis-B virus infection is globally ubiquitous, but its distribution is very heterogeneous, with prevalence of serological markers in various nations ranging from less than 1% to more than 90%. We propose an explanation for this diversity using a mathematical model of hepatitis-B virus transmission dynamics that shows, for the first time, 'catastrophic' behavior using realistic epidemiological processes and parameters. Our major conclusion is that the prevalence of infection is largely determined by a feedback mechanism that relates the rate of transmission, average age at infection and age-related probability of developing carriage following infection. Using the model we identify possible, highly non-linear, consequences of chemotherapy and immunization interventions, for which the starting prevalence of carriers is the most influential, predictive quantity. Taken together, our results demand a re-evaluation of public health policy towards hepatitis-B.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Maynard, J.E., Kane, M.A., Alter, M.J. & Hadler, S.C. Hepatitis B by immunisation: global perspectives. In Viral Hepatitis and Liver Disease (ed. Zuckerman, A.J.) 967–969 (Alan R. Liss Inc., New York, 1988).
Mayans, M.V. et al. Do bedbugs transmit hepatitis B? Lancet 343, 761–763 (1994).
Mayans, M.V. et al. Risk factors for the transmission of hepatitis B virus to Gambian children. Lancet 336, 1107–1109 (1990).
Whittle, H.C. et al. Hepatitis B virus infection in two Gambia villages. Lancet 1, 1203–1206 (1983).
Schreeder, M.J. et al. Prevalence of hepatitis B in selected Alaskan Eskimo villages. Am. J. Epidemiol . 118, 543–549 (1983).
Mortimer, P.P. & Miller, E. Antenatal screening and targeting should be sufficient in some countries. Br. Med. J. 314, 1036–1037 (1997).
O'Connell, T. et al. Prevalence of hepatitis-B anti-core antibody in the Republic of Ireland. Epidemiol. Infect. 125, 701–704 (2000).
Anderson, R.M. & May, R.M. Infectious Diseases of Humans: Dynamics and Control . (Oxford University Press, 1991).
Anderson, R.M., Medley, G.F. & Nokes, D.J. Preliminary analyses of the predicted impacts of various vaccination strategies on the transmission of hepatitis B virus. In The Control of Hepatitis B: The Role of Prevention in Adolescence. (ed. Bennet, D.L.) 95–130 (Gower Medical, London, 1992).
Edmunds, W.J., Medley, G.F. & Nokes, D.J. The transmission dynamics and control of hepatitis B virus in a developing country. Stats. Med. 15, 2215–2233 (1996).
Zhao, S., Xu, Z. & Lu, Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int. J. Epidemiol. 29, 744–752 (2000).
Williams, J.R., Nokes, D.J., Medley, G.F. & Anderson, R.M. The transmission dynamics of hepatitis-B in the UK: a mathematical model for evaluating costs and effectiveness of immunisation programmes. Epidemiol. Infect. 116, 71–89 (1996).
Edmunds, W.J. Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies. Comm. Dis. Pub. Health 1, 221–228 (1998).
Edmunds, W.J., Medley, G.F. & Nokes, D.J. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stats. Med. 18, 3263–3282 (1999).
McMahon, B.J. et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J. Infect. Dis. 151, 599–603 (1985).
Hyams, K.C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin. Infect. Dis. 20, 992–1000 (1995).
Edmunds, W.J., Medley, G.F., Nokes, D.J., Hall, A.J. & Whittle, H.C. The influence of age on the development of the hepatitis B carrier state. Proc. Roy. Soc. Lond. Ser. B. 253, 197–201 (1993).
Panagiotopoulos, T., Antoniadou, I. & Valassi-Adam, E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. Br. Med. J. 319, 1462–1467 (1999).
Dushoff, J. Incorporating immunological ideas in epidemiological models. J. Theor. Biol. 180, 181–187 (1996).
Dushoff, J., Huang, W. & Castillo-Chavez, C. Backwards bifurcations and catastrophe in simple models of fatal diseases. J. Math. Biol. 36, 227–248 (1998).
Hadeler, K.P. & Castillo-Chavez, C. A core group model for disease transmission. Math. Biosci. 128, 41–58 (1995).
van den Driessche, P. & Watmough, J. A simple SIS epidemic model with a backward bifurcation. J. Math. Biol. 40, 525–540 (2000).
Wodarz, D. & Nowak, M.A. Specific therapy regimes could lead to long-term immunological control of HIV. Proc. Nat. Acad. Sci. USA 96, 14464–14469 (1999).
Kuznetsov, Y.A. & Piccardi, C. Bifurcation analysis of periodic SEIR and SIR epidemic models. J. Math. Biol. 32, 109–21 (1994).
Greenhalgh, D., Diekmann, O. & de Jong, M.C.M. Subcritical endemic steady states in mathematical models for animal infections with incomplete immunity. Math. Biosci. 165, 1–25 (2000).
Simon, C.P. & Jacquez, J. Reproduction numbers and the stability of equilibria of SI models for heterogeneous populations. SIAM J. Appl. Math. 52, 541–576 (1996).
Huang, W., Cooke, K.L. & Castillo-Chavez, C. Stability and bifurcation for a multiple-group model for the dynamics of HIV/AIDS transmission. SIAM J. Appl. Math. 52, 835–854 (1992).
Hadeler, K.P. & van den Driessche, P. Backward bifurcation in epidemic control. Math. Biosci. 146, 15–35 (1997).
Poston, T. & Stewart, I. Castrophe Theory and Its Application. (Pitman, San Francisco, 1978).
Hill, A.V. The immunogenetics of human infectious diseases. Ann. Rev. Immunol. 16, 593–617 (1998).
Thursz, M.R. et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. New Engl. J. Med. 332, 1995–1999 (1995).
Edmunds, W.J. et al. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol. Infect. 117, 313–325 (1996).
Wilson, J.N., Nokes, D.J. & Carman, W.F. Predictions of the emergence of vaccine-resistant hepatitis B in The Gambia using a mathematical model. Epidemiol. Infect. 124, 295–307 (2000).
Gay, N.J. & Edmunds, W.J. Developed countries could pay for hepatitis B vaccination in developing countries. Br. Med. J. 316, 1457 (1998).
Okoth, F.A. et al. Seroepidemiological study for HBV markers and anti-delta in Kenya. East Afr. Med. J. 68, 515–523 (1991).
McLean, A.R. & Blumberg, B.S. Modelling the impact of mass vaccination against hepatitis B. I Model formulation and parameter estimation. Proc. Roy. Soc. Lond. B 256, 7–15 (1994).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Medley, G., Lindop, N., Edmunds, W. et al. Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control. Nat Med 7, 619–624 (2001). https://doi.org/10.1038/87953
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/87953
This article is cited by
-
Modelling disease transmission through asymptomatic carriers: a societal and environmental perspective
International Journal of Dynamics and Control (2024)
-
Modelling the dynamics of acute and chronic hepatitis B with optimal control
Scientific Reports (2023)
-
Mathematical model analysis of effective intervention strategies on transmission dynamics of hepatitis B virus
Scientific Reports (2023)
-
Optimal Control of Hepatitis B in a sub-Saharan African rural area
Applied Mathematics-A Journal of Chinese Universities (2023)
-
Mathematical analysis of hepatitis B epidemic model with optimal control
Advances in Difference Equations (2021)